Systems Biology in Cancer Research and Drug DiscoveryAsfar S Azmi Springer Science & Business Media, 29.09.2012 - 423 Seiten Systems Biology in Cancer Research and Drug Discovery provides a unique collection of chapters, by world-class researchers, describing the use of integrated systems biology and network modeling in the cancer field where traditional tools have failed to deliver expected promise. This book touches four applications/aspects of systems biology (i) in understanding aberrant signaling in cancer (ii) in identifying biomarkers and prognostic markers especially focused on angiogenesis pathways (iii) in unwinding microRNAs complexity and (iv) in anticancer drug discovery and in clinical trial design. This book reviews the state-of-the-art knowledge and touches upon cutting edge newer and improved applications especially in the area of network modeling. It is aimed at an audience ranging from students, academics, basic researcher and clinicians in cancer research. This book is expected to benefit the field of translational cancer medicine by bridging the gap between basic researchers, computational biologists and clinicians who have one ultimate goal and that is to defeat cancer. |
Im Buch
Ergebnisse 1-5 von 51
... biology: 1. Founding principles and scale laws. Prog Biophys Mol Biol 97:79–114 Bailey JE (1999) Lessons from metabolic engineering for functional genomics and drug discovery. Nat Biotechnol 17:616–618 Banki K, Hutter E, Colombo E et al ...
... Biol Chem 276:37747–37753 Boros LG, Williams RD (2001) Isofenphos induced metabolic changes in K562 myeloid blast cells. Leuk Res 25:883–890 Boros LG, Torday JS, Lim S et al (2000) Transforming growth factor beta2 promotes glucose ...
... Biol Chem 274:17410–17416 Elson DA, Ryan HE, Snow JW et al (2000) Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res 60:6189 ...
... Biol 27:65–104 Kacser H, Small JR (1996) How may phenotypes from one genotype? The case of prion diseases. J Theor Biol 182:209–218 Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug ...
... Biol Chem 272:4941–4952 Mazurek S, Eigenbrodt E, Failing K et al (1999) Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells. J Cell Physiol 181:136–146 Mazurek S, Grimm H ...
Inhalt
Systems Approaches to Understand Cancer Progression | 165 |
Systems and Network Biology in Decoding miRNA Complexity | 246 |
Network Modeling in Cancer Drug Discovery and Clinical Trials | 307 |
Erratum | 418 |
Index | 419 |